These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 6408408

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Some cardiovascular effects of monoamine oxidase inhibitors in unanaesthetized rats.
    Marwood JF, Huston V, Wall KT.
    Clin Exp Pharmacol Physiol; 1985; 12(2):161-8. PubMed ID: 3839173
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of reserpine on body temperature in the rat after pretreatment with amphetamine and monoamineoxidase inhibitors.
    Cremades A, Serrano JS, Jané F, Milanés MV.
    Methods Find Exp Clin Pharmacol; 1982; 4(8):563-8. PubMed ID: 7169843
    [Abstract] [Full Text] [Related]

  • 7. Effect of monoamineoxidase inhibitors on 5-hydroxytryptamine output from perfused cerebral ventricles of anaesthetized cats.
    Goodrich CA.
    Br J Pharmacol; 1969 Sep; 37(1):87-93. PubMed ID: 4390487
    [Abstract] [Full Text] [Related]

  • 8. Cumulative effects of irreversible MAO inhibitors in vivo.
    Felner AE, Waldmeier PC.
    Biochem Pharmacol; 1979 Apr 01; 28(7):995-1002. PubMed ID: 444293
    [No Abstract] [Full Text] [Related]

  • 9. Experimental observations on the effects of adrenaline after treatment with antidepressant monoamine oxidase inhibitor (MAOI) drugs.
    Trinker FR, Fearn H, McCulloch MW, Rand MJ.
    Aust Dent J; 1967 Aug 01; 12(4):297-303. PubMed ID: 5233628
    [No Abstract] [Full Text] [Related]

  • 10. Monoamine oxidase inhibiting properties of SU-11,739 in the rat. Comparison with pargyline, tranylcypromine and iproniazid.
    Maître L.
    J Pharmacol Exp Ther; 1967 Jul 01; 157(1):81-8. PubMed ID: 6029494
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evidence that a preferred substrate for type B monoamine oxidase mediates stimulus properties of MAO inhibitors: a possible role for beta-phenylethylamine in the cocaine cue.
    Colpaert FC, Niemegeers CJ, Janssen PA.
    Pharmacol Biochem Behav; 1980 Oct 01; 13(4):513-7. PubMed ID: 6107935
    [Abstract] [Full Text] [Related]

  • 15. Effects of the monoamine oxidase inhibitors pargyline and tranylcypromine on cellular proliferation in human prostate cancer cells.
    Lee HT, Choi MR, Doh MS, Jung KH, Chai YG.
    Oncol Rep; 2013 Oct 01; 30(4):1587-92. PubMed ID: 23900512
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of insulin release by substrates and inhibitors of monoamine oxidase.
    Aleyassine H, Lee SH.
    Am J Physiol; 1972 Mar 01; 222(3):565-9. PubMed ID: 5022664
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of certain monoamine oxidase inhibitors on isoproterenol-induced cardiac necrosis in rats.
    Stanton HC, Schwartz A.
    Proc West Pharmacol Soc; 1966 Mar 01; 9():6-8. PubMed ID: 4381147
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Monoamine oxidase in pancreatic islets, exocrine pancreas, and liver from rats. Characterization with clorgyline, deprenyl, pargyline, tranylcypromine, and amezinium.
    Lenzen S, Nahrstedt H, Panten U.
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Nov 01; 324(3):190-5. PubMed ID: 6419132
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.